Stockscreener 앱 받기
7.23
2.03%
-0.15
전일 마감가:
$7.38
열려 있는:
$7.43
하루 거래량:
104.63K
Relative Volume:
0.66
시가총액:
$270.88M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
144.60
EPS:
0.05
순현금흐름:
$-8.79M
1주 성능:
-8.48%
1개월 성능:
-4.37%
6개월 성능:
+0.14%
1년 성능:
+26.40%
1일 변동 폭
$7.16
$7.43
1주일 범위
$7.16
$8.1799
52주 변동 폭
$4.76
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.23 | 276.50M | 128.45M | 6.54M | -8.79M | 0.05 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 개시 | William Blair | Outperform |
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
(LFCR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Aug Reactions: What drives Lifecore Biomedical Incs stock priceMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
2026-02-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Can Lifecore Biomedical Inc continue delivering strong returnsJuly 2025 Selloffs & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is OPTT vulnerable to short sellersRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Portfolio Shifts: Is Lifecore Biomedical Inc a strong candidate for buy and holdIndex Update & Risk Controlled Swing Alerts - baoquankhu1.vn
Notice to Long-Term Shareholders of Lifecore Biomedical, - GlobeNewswire
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
2026-01-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Is Lifecore Biomedical Inc. a defensive stockTrade Entry Summary & Free Community Supported Trade Ideas - mfd.ru
(LFCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
2026-01-25 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Aug PreEarnings: Is Lifecore Biomedical Inc trading at a discountJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-01-20 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity - simplywall.st
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
2026-01-18 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
(LFCR) Risk Channels and Responsive Allocation - Stock Traders Daily
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit - Law360
Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan - TipRanks
What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage? - Insider Monkey
Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire
Townhall - FinancialContent
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
Whittier Daily News - FinancialContent
Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Clai - GlobeNewswire
Insider Trends: Why Lifecore Biomedical Inc stock could rally in 20252025 Risk Factors & Stepwise Trade Signal Guides - Bộ Nội Vụ
Aug Selloffs: Why Lifecore Biomedical Inc. stock attracts high net worth investors2025 Market Sentiment & Stock Market Timing Techniques - Улправда
Pullback Watch: Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - ulpravda.ru
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Beh - GlobeNewswire
About Us - FinancialContent
Why Lifecore Biomedical Inc. stock attracts high net worth investorsDividend Hike & Low Volatility Stock Recommendations - Улправда
Is Lifecore Biomedical Inc. stock dividend yield sustainableWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Why Lifecore Biomedical Inc. stock could rally in 2025July 2025 Volume & Risk Adjusted Buy and Sell Alerts - Улправда
How institutional buying supports Lifecore Biomedical Inc. stock2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
Why Lifecore Biomedical Inc. stock is a must watch in 2025Market Activity Recap & Weekly Setup with ROI Potential - Улправда
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.15%
자본화:
|
볼륨(24시간):